The Psychology Digest

There’s a lot happening over here as we develop the new WAIS-5 A&NZ. We wanted to share our latest updates as we get closer to releasing this new assessment. The Wechsler Adult Intelligence Scale®, Fifth Edition: Australian and New Zealand Language Standardised Edition (WAIS®-5 A&NZ) is the most advanced psychometric measure of cognitive abilities and now it can be administered in less time. And that is not all! WAIS-5 A&NZ also features updated norms, expanded clinical utility, and improved user experience.

Check out the latest details on these enhancements, plus learn about five of the new subtests.

The Bruininks-Oseretsky Test of Motor Proficiency™, Third Edition (BOT™-3) is one of the most-anticipated product updates of the year, and we know you’ve got questions! We sat down with the BOT-3 authors, Drs. Brett and Bob Bruininks, to talk about customer- and research-led updates to this widely used motor skills assessment, and all the new features you can expect to see when it releases later this year.

Questions answered by Lancaster University Lecturer, Dr Calum Hartley, and Lancaster University student with ASD, Mollie Lee.

Case study: Sensory Profile 2

Dr. Lynsey Psimas, Ph.D and Dr. Paul Williams PsyD attended CNS Summit 2023 and were fortunate to have the opportunity to present their poster, Precision Matters: An Analysis on How Various Scores Behave When Measuring Change Over Time; Factors That Inform Score Selection for the Best Results”.

With more responsibilities and obligations on their plates than ever before, adults are combating increased stress on a daily basis. In fact, in a report released by the American Psychological association, 27% of adults reported that on most days, they are too stressed to function. “Nearly half (46%) of those under 35 and more than half (56%) of Black adults under 35 agreed with this statement.1” This increased stress is directly affecting their well-being and quality of life and can lead to a variety of medical health conditions and issues with substance abuse. As mental health and wellness concerns rise, it can be difficult for practitioners to keep up with the demand, leaving many individuals without the care many so desperately need.

The Dyslexia Resource Center, founded in Baton Rouge, LA, is trailblazing a clear path through effective dyslexia identification and support, but they’re not stopping there. Through a three-phase approach of research, identification, and support, every member of their team — at each of their locations — is following their passion to serve their surrounding communities through tutoring for students with dyslexia, caregiver support, and educator training. 

“Rare Genetic/Monogenic Disorders & Co-Occurring Conditions in Intellectual and Developmental Disabilities”

Each year, Gatlinburg brings together numerous behavioral scientists from around the world to discuss their research and collaborations in related fields such as intellectual and developmental disabilities. While it is a smaller conference, the attendees represent all professional levels and include students, post-docs, support and research staff, professors, and researchers. Our Pharma Services team also attended, excited to learn about the important and ground-breaking research being conducted in the IDD sphere.

Presenters: Lynsey Psimas, PhD and Paul Williams PsyD

Growth Scale Values (GSVs) have a long 50-year history within research. However, GSVs are only now gaining traction as an alternative and more precise way to measure outcomes in clinical trials.

In testing and in research, you must have an effective and reliable way to measure change. While raw scores have typically been the go-to for this important role, Growth Scale Values (GSVs) are quickly becoming the preferred method.

Our Director of Pharma Sales, Lynsey Psimas, had the opportunity to speak with Mark Daniel, author of Growth Scale Value (GSV): Theory, Development, and Applications to discuss the importance of GSVs. He spent some time explaining GSVs and their importance in test scoring and pharma research.